Shi LH - Search Results

1

Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.

Wang K, Liu J, Yan ZL, Li J, Shi LH, Cong WM, Xia Y, Zou QF, Xi T, Shen F, Wang HY, Wu MC. Wang K, et al. Among authors: shi lh. Hepatology. 2010 Jul;52(1):164-73. doi: 10.1002/hep.23650. Hepatology. 2010. PMID: 20578260

2

Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.

Lu ZH, Shen F, Yan ZL, Li J, Yang JH, Zong M, Shi LH, Wu MC. Lu ZH, et al. Among authors: shi lh. J Cancer Res Clin Oncol. 2009 Jun;135(6):783-9. doi: 10.1007/s00432-008-0513-0. Epub 2008 Nov 26. J Cancer Res Clin Oncol. 2009. PMID: 19034515

3

[Clinical study of 169 patients with hepatic angiomyolipoma].

Yu F, Wang K, Yan ZL, Zhang XF, Li J, Dong H, Cong WM, Shi LH, Shen F, Wu MC. Yu F, et al. Among authors: shi lh. Zhonghua Wai Ke Za Zhi. 2010 Nov 1;48(21):1621-4. Zhonghua Wai Ke Za Zhi. 2010. PMID: 21211255 Chinese.

4

A case-control study of correlation between preoperative serum AFP and recurrence of hepatocellular carcinoma after curative hepatectomy.

Xia Y, Yan ZL, Xi T, Wang K, Li J, Shi LH, Wu MC, Shen F. Xia Y, et al. Among authors: shi lh. Hepatogastroenterology. 2012 Oct;59(119):2248-54. doi: 10.5754/hge11978. Hepatogastroenterology. 2012. PMID: 22366528

5

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.

Xi T, Lai EC, Min AR, Shi LH, Wu D, Xue F, Wang K, Yan Z, Xia Y, Shen F, Lau WY, Wu MC. Xi T, et al. Among authors: shi lh. Hepatogastroenterology. 2012 Jun;59(116):1198-203. doi: 10.5754/hge09654. Hepatogastroenterology. 2012. PMID: 22580673

6

Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.

Liu J, Liu JF, Wang K, Yan ZL, Wan XY, Huang AM, Wang YZ, Li J, Xia Y, Shi LH, Jiao BH, Zhang Y, Shen F. Liu J, et al. Among authors: shi lh. Oncol Rep. 2015 Dec;34(6):3174-86. doi: 10.3892/or.2015.4300. Epub 2015 Sep 21. Oncol Rep. 2015. PMID: 26398566

7

A novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy.

Huang LF, Xing X, Wu D, Xia Y, Li J, Wang K, Yan ZL, Wan XY, Shi LH, Yang T, Lau WY, Wu MC, Shen F. Huang LF, et al. Among authors: shi lh. Oncotarget. 2016 May 3;7(18):25493-506. doi: 10.18632/oncotarget.8333. Oncotarget. 2016. PMID: 27027439 Free PMC article.

8

Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.

Xia Y, Qiu Y, Li J, Shi L, Wang K, Xi T, Shen F, Yan Z, Wu M. Xia Y, et al. Ann Surg Oncol. 2010 Dec;17(12):3137-44. doi: 10.1245/s10434-010-1148-3. Epub 2010 Jul 3. Ann Surg Oncol. 2010. PMID: 20602260 Clinical Trial.

9

Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.

Cai X, Zhai J, Kaplan DE, Zhang Y, Zhou L, Chen X, Qian G, Zhao Q, Li Y, Gao L, Cong W, Zhu M, Yan Z, Shi L, Wu D, Wei L, Shen F, Wu M. Cai X, et al. Hepatology. 2012 Nov;56(5):1804-16. doi: 10.1002/hep.25874. Epub 2012 Jun 25. Hepatology. 2012. PMID: 22684921 Free PMC article.

10

A prognostic scoring system for patients with multiple hepatocellular carcinomas treated by hepatectomy.

Yang P, Wu D, Xia Y, Li J, Wang K, Yan Z, Shi L, Lau WY, Wu M, Shen F. Yang P, et al. Ann Surg Oncol. 2015 Mar;22(3):826-33. doi: 10.1245/s10434-014-4081-z. Epub 2014 Sep 13. Ann Surg Oncol. 2015. PMID: 25216602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters